Age dependent impact of LMP polymorphisms on TNFalpha-induced apoptosis in human peripheral blood mononuclear cells.
As a consequence of inflammatory stimuli (such as TNFalpha and IFNgamma), some constitutive subunits of the proteasome, the principal mediator of nonlysosomal protein degradation, are replaced with other subunits, the large multifunctional proteases LMP2 and LMP7, thus originating the immunoproteasome. An age-related alteration of proteasome activity and susceptibility to TNFalpha-induced apoptosis, in which LMP2 and the nuclear factor (NF)-kappaB activation play an important role has been recently reported. In this paper, we investigated the possible influence of two LMP2 and LMP7 polymorphisms on susceptibility to TNFalpha-induced apoptosis. Our data show that an increase in susceptibility to TNFalpha-induced apoptosis is evident in long-lived people (aged >88 years) in comparison to young individuals. Moreover, the modulation of LMP2 codon 60 polymorphism on TNFalpha-induced apoptosis is evident in long-lived subjects. Genotyping of 311 young people and 157 nonagenarians and centenarians revealed no changes in LMP2 codon 60 genotype frequency distribution. No correlation with TNFalpha-induced apoptosis and no difference in frequency between young people and nonagenarians/centenarians was observed when the LMP7 nucleotide 145 polymorphism was studied.
Mishto
M
M
Department of Experimental Pathology, University of Bologna, Via San Giacomo 12, 40126 Bologna, Italy.
Bonafè
M
M
Salvioli
S
S
Olivieri
F
F
Franceschi
C
C
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000235:genetics* / Q000276:immunology; D017209:Apoptosis / Q000235:genetics* / Q000276:immunology; D002478:Cells, Cultured; D003546:Cysteine Endopeptidases; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects / Q000276:immunology; D008136:Longevity; D008285:Major Histocompatibility Complex / Q000235:genetics*; D009097:Multienzyme Complexes; D011110:Polymorphism, Genetic; D046988:Proteasome Endopeptidase Complex; D011506:Proteins / Q000235:genetics*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology / Q000494:pharmacology
D009097:Multienzyme Complexes; D011506:Proteins; D014409:Tumor Necrosis Factor-alpha; C071313:LMP-2 protein; D003546:Cysteine Endopeptidases; C077436:LMP7 protein; D046988:Proteasome Endopeptidase Complex